Katherine A. McGlynn, PhD

National Cancer Institute
Bethesda, Maryland, United States

Presentation(s):

• (OR37-03-24) Sugar- and Artificially Sweetened Beverages, Proteomic Signatures, and Risk of Liver Outcomes: A Prospective Cohort Study in the UK Biobank

  Tuesday, July 2, 2024
  10:24 AM – 10:36 AM CT

  Disclosure information not submitted.